NKGen Biotech- Warrants (01/09/2028) Long Term Debt

The latest long-term debt for NKGNW is $11M as of March 2025. That compares with $10M in the prior-year period — up 11.2% year over year. Investors often review this figure alongside NKGen Biotech- Warrants (01/09/2028)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, NKGNW's long-term debt moved from $10M to $11M — a 11.2% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in NKGen Biotech- Warrants (01/09/2028)'s operating scale or balance-sheet position.

A long-term debt figure of $11M for NKGNW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting NKGNW's long-term debt ($11M), review year-over-year change from $10M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.